Telmisartan Plus Tablet 80/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled with Telmisartan alone, take one dose daily with a drink, regardless of meal timing. It is recommended to adjust the dosage of each component separately before switching to this fixed-dose combination medication. It may be considered to directly switch from monotherapy if clinically appropriate. - Telmisartan/Hydrochlorothiazide combination 40/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 40 mg of Telmisartan. - Telmisartan/Hydrochlorothiazide combination 80/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 80 mg of Telmisartan. - Telmisartan/Hydrochlorothiazide combination 80/25 mg can be administered to patients whose blood pressure is not adequately controlled with 80 mg of Telmisartan and 12.5 mg of Hydrochlorothiazide, whether single or combination therapy. Sodium or volume depletion should be corrected before starting this medication. For renal impairment patients: No dose adjustment is necessary for patients with mild-to-moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance <30 mL/min). Regular monitoring of renal function is recommended. For liver impairment patients: Caution is advised for administering this medication to patients with mild-to-moderate liver impairment. It should not be given in doses exceeding 40/12.5 mg per day. This medication should not be administered to patients with severe liver impairment (see Note 2 in the precautions for use). Thiazide diuretics should be used with caution in patients with impaired liver function. For elderly patients: No dose adjustment necessary. For children: Safety and efficacy have not been established for pediatric patients under 18 years of age.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any components or additives of this medication, as well as pregnant or breastfeeding women, or individuals with severe liver or kidney disease should not use it. Elderly patients, those with hyperkalemia, liver disease patients, and those with heart valve diseases should use this medication with caution. The Hydrochlorothiazide component can cause electrolyte imbalance in the body, so potassium, sodium levels, and other values should be monitored regularly with blood tests. Adverse reactions such as dizziness, low blood pressure, cardiac abnormalities, skin rashes, etc., may occur during the intake of this medication; if symptoms arise, consult a doctor immediately. When taken with other blood pressure medications, diuretics, lithium, or drugs that affect blood potassium levels, there is a potential for interactions, so follow the advice of a healthcare professional. Women planning or currently pregnant should use alternative treatments that have proven safety instead of this medication, and do not administer it while breastfeeding. Overdose can lead to low blood pressure, electrolyte disturbances, dehydration, etc., so strict adherence to the dosage must be maintained, and if abnormal symptoms occur, visit a medical institution immediately. Safety and efficacy in children have not been established; therefore, it is not recommended. While taking this medication, caution is needed as dizziness or drowsiness may occur when driving or operating machinery. This medication may be sensitive to light; therefore, avoid excessive exposure to sunlight and consult a doctor immediately if any skin abnormalities occur. Store it in a tightly closed container away from air and moisture, and ensure it is kept out of reach of children. It should be taken out of the packaging just before use.

Serious side effects

• Urticaria
• severe swelling (edema)
• angioedema
• chest tightness
• difficulty breathing
• angioedema (including fatal outcomes)
• anaphylactic reactions
• severe rash with high fever
• blisters
• peeling skin

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, visual impairment, blurred vision, lightheadedness, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, cough, pulmonary inflammation, pulmonary edema, diarrhea, dry mouth, flatulence, abdominal pain, constipation, dyspepsia, vomiting, liver function abnormalities/liver disease, erythema, pruritus, rash, hyperhidrosis, urticaria, etc.

This medication should be stored in a tightly closed container to avoid exposure to air or moisture and should be kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will safely preserve the effectiveness of the medication.

Appearance

An oval tablet that consists of two layers, white and pink, with possible pink specks on the white layer.

Package unit

30 tablets/box (10 tablets/PTP x 3)